CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients

Journal of Clinical Virology

Volumn 56, Issue 2, 2013, Pages 108-112

  Cardeñoso, Laura ^a   Pinsky, Benjamin A ^b   Lautenschlager, Irmeli ^c   Aslam, Shagufta ^d   Cobb, Bryan ^d   Vilchez, Regis A ^d,h   Hirsch, Hans H ^e,f,g  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d ROCHE MOLECULAR SYSTEMS   (United States)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h ABBOTT LABORATORIES   (United States)

Author keywords

Antigenemia; Cytomegalovirus; PCR; QNAT; Standardization

Indexed keywords

ANTIGEN DETECTION; ARTICLE; CYTOMEGALOVIRUS INFECTION; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; WORLD HEALTH ORGANIZATION;

ADULT; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOASSAY; MIDDLE AGED; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION; VIRAL LOAD; YOUNG ADULT;

EID: 84872403604     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.10.001     Document Type: Article

References (18)

1. Boeckh M., Ljungman P. How I treat cytomegalovirus in hematopoietic cell transplant recipients. Blood 2009, 113:5711-5719.
2. Halfon P., Berger P., Khiri H., Martineau A., Penaranda G., Merlin M., et al. Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoitic cell transplantation. J Med Virol 2011, 83:490-495.
3. Pang X.L., Fox J.D., Fenton J.M., Miller G.G., Caliendo A.M., Preiksaitis J.K., et al. Interlaboratory comparison of cytomegalovirus viral load assays. Am J Transplant 2009, 9:258-268.
4. Caliendo A., Shahbazian M.D., Schaper C., Ingersoll J., Abdul-Ali D., Boonyaratanakornkit J., et al. A commutable cytomegalovirus calibrator is required to improve the agreement of viral load values between laboratories. Clin Chem 2009, 55:1701-1710.
5. Freyer JF, Heath AB, Anderson R, Minor PD, Collaborative Study Group. Collaborative study to evaluate the proposed 1st WHO international standard for human cytomegalovirus for nucleic acid amplification-based assays. WHO/BS/10.2138, Geneva, 18-22 October 2010. p. 1-40.
6. Marty F.M., Ljungman P., Papanicolaou G.A., Winston D.J., Chemaly R.F., Strasfeld L., et al. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogenic stem cell transplants: a phase 3, double-blind, placebo-controlled, randomized trial. Lancet Infect Dis 2011, 11:284-292.
7. Caliendo A.M., Shuurman R., Yen-Lieberman B., Spector S.A., Andersen J., Manjiry R., et al. Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol 2001, 39:1334-1338.
8. Clinical Laboratory Standards Institute (CLSI). EP9-A2. Method comparison and bias estimation using patient samples. Approved guideline. 2nd ed; 20 September 2002.
9. COBAS® TaqMam® CMV test FDA approved package insert, July 2012.
10. Clinical Laboratory Standards Institute (CLSI). EP12-A2. User protocol for the evaluation of qualitative test performance. Approved guideline. 2nd ed. vol. 28, No. 3; 2008.
11. Kullberg-Lindh C., Olofsson S., Brune M., Lindh M. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA. Transpl Infect Dis 2008, 10:308-315.
12. Lisboa L.F., Asberg A., Kumar D., Pang X., Hartmann A., Preiksaitis J.K., et al. The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation 2011, 91:231-236.
13. Piiparinen H., Hockerstedt K., Gronhagen-Riska C., Lautenschlager I. Comparison of teo quantitative CMV PCR tests, Cobas Amplicor CMV monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J Clin Virol 2004, 30:258-266.
14. Beckman C., Dumoulin A., Rinaldo C.H., Hirsch H.H. Comparison of a UL111a real-time PCR and pp65 antigenemia for the detection of cytomegalovirus. J Med Virol 2011, 83:2143-2150.
15. Marchetti S., Santangelo R., Manzara S., D'onghia S., Fadda G., Cattani P. Comparison of real-time PCR and pp65 antigen assays for monitoring the development of cytomegalovirus disease in recipients of solid organ and bone marrow transplants. New Microbiol 2011, 157:157-164.
16. Emery V.C., Sabin C.A., Cope A.V., Gor D., Hassan-Walker A.F., Griffiths P.D. Application of viral load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000, 355:2032-2036.
17. Funk G.F., Gosert R., Hirsch H.H. Viral dynamics in transplant patients: implications for disease. Lancet Infect Dis 2007, 7:460-472.
18. Waggoner J., Ho D.Y., Libiran P., Pinsky B.A. Clinical significance of low cytomegalovirus DNA levels in human plasma. J Clin Microbiol 2012, 50:2378-2383.